7 million and the subsequent estimated $5.6 million in contracted European shipments in the next 18 months would position the Company to be a significant international producer of medical cannabis products,” Symmes said.

Original Release: https://www.globenewswire.com/news-release/2023/02/13/2606529/0/en/Aleafia-Health-Announces-Q3-FY2023-Results-International-Expansion-and-Second-Quarter-of-Profitability.html

Previous Post
Embarassed CEO Comes Clean-Lied to Princess and Investors About Timeline.
Next Post
Reckless CEO Fibs To Keep Co. Afloat - Big Mistakes Ahead?